Physician profile
Kellen Sherlock
NPI 1518221662
$520.79
in general payments reported to CMS, 2019-2025
9 companies · $49.71 in 2025
The $49.71 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $15.28 · 2021: $112 · 2023: $67.16 · 2024: $32.52 · 2025: $49.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $186.00 | 2019 | |
| Abbvie INC. | $82.88 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $63.25 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Vapotherm INC | $57.93 | 2019 | |
| Mylan Specialty L.P. | $49.96 | 2023 | Yupelri |
| Amgen INC. | $29.31 | 2021 | |
| Baxter Healthcare | $20.39 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $15.79 | 2025 | |
| Astellas Pharma US INC | $15.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellen Sherlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.